92% probability Samvardhana Motherson reports consolidated revenue from operations of at least Rs 33,000 crore in Q2 FY2027. Q1 was a record Rs 35,243.8 crore, up 16.65% year-on-year. The threshold is set 6.4% lower because Q2 contains the European summer plant shutdowns.
Samvardhana Motherson International reported Q1 FY2027 consolidated revenue from operations of Rs 35,243.8 crore, up 16.65% from Rs 30,212.0 crore in the corresponding quarter, its highest-ever quarterly revenue. Consolidated net profit was Rs 1,075.7 crore. Total income rose 16.6% year-on-year. Source: Samvardhana Motherson Q1 FY2027 results.
We lock a binary: Samvardhana Motherson's reported consolidated revenue from operations for Q2 FY2027 is Rs 33,000 crore or higher. Confidence 92%.
Q1 FY2027 was a record Rs 35,243.8 crore, up 16.65% year-on-year. Our threshold is 6.4% below that.
Motherson is easy to misread as a domestic auto play. It is not. A majority of group revenue comes from international operations supplying global OEMs, which means the Indian festive build is only part of the picture and the European calendar is the other part. The quarter ending 30 September contains the European summer plant shutdowns, when customer assembly lines stop for maintenance and component demand falls with them. A sequential decline in Q2 is therefore normal for this business in a way it would not be for a purely domestic supplier.
That is why the buffer is 6.4% rather than the 4.4% we set on Max Healthcare, whose Q2 is seasonally strong. The floors in this tranche are not a uniform haircut applied for the appearance of caution. Each is sized to the specific seasonality and specific downside of the business it covers, which is the only way a set of high-confidence locks stays honest rather than becoming a row of near-certainties dressed up as forecasts.
The residual 8% is the automotive cycle itself, plus acquisition accounting. Motherson grows partly by acquisition, and a consolidation that lands mid-quarter can move the reported line in either direction. A genuine downturn in European or North American light-vehicle production is the main path to a miss.
RAOSCAFF locks P-234 on 2026-08-29, before the Q2 FY2027 release. Scored against the consolidated revenue from operations figure published in the company's Q2 FY2027 results.
The buffer here is 6.4% against 4.4% on Max Healthcare, because this quarter contains the European summer shutdowns and that one contains the Indian monsoon admissions peak. The floors are sized to the business, not applied uniformly.